Skip to main content
. 2018 Aug 11;5(1):34–40. doi: 10.1016/j.wjorl.2018.05.006

Table 2.

Surgical management of anaplastic thyroid cancer patients [No. (%)].

Surgery Type Total 1973–1974 1975–1979 1980–1984 1985–1989 1990–1994 1995–1999 2000–2004 2005–2009 2010–2014 P value
None 725 (47.5) 0 1 (2.7) 2 (4.9) 9 (19.6) 35 (37.6) 58 (37.6) 161 (55.5) 202 (51.7) 257 (54.6) <0.001
Lobectomy and/or isthmectomy 141 (9.2) 0 0 0 3 (6.5) 6 (6.5) 20 (13.0) 28 (9.7) 42 (10.7) 42 (8.9)
ST/NT 94 (6.2) 0 0 0 3 (6.5) 9 (9.7) 9 (5.8) 19 (6.6) 23 (5.9) 31 (6.6)
TT 300 (19.6) 0 0 0 2 (4.3) 17 (18.3) 35 (22.7) 52 (17.9) 89 (22.8) 105 (22.3)
Thyroidectomy NOS 14 (0.9) 0 0 0 1 (2.2) 1 (1.1) 4 (2.6) 3 (1.0) 1 (0.3) 4 (0.8)
Othera 253 (16.6) 4 (100.0) 36 (97.3) 39 (95.1) 28 (60.9) 25 (27.0) 28 (18.1) 27 (9.3) 34 (8.6) 32 (6.7)

ST/NT: Subtotal/Near Total Thyroidectomy, TT: Total Thyroidectomy, NOS: Not Otherwise Specified, P < 0.05 = significant.

a

Other includes: Surgery NOS, Unknown Surgery Status, and Incisional/Aspiration Biopsy or Local Excision.